September 30, 2024 04:05 PM Eastern Time
Repare Therapeutics Announces Phase 1 Data Highlighting Camonsertib in Combination with Radiotherapy Treatment Presented at the ASTRO Annual Meeting
Download
Small
JPEG, 268x80, 19.3 KB
Preview
JPEG, 144x43, 10.5 KB
Thumbnail
JPEG, 120x36, 8.6 KB
Smart Multimedia Gallery
Share
Facebook
Twitter
LinkedIn
Delicious
Reddit
StumbleUpon
Digg
MySpace
Newsvine
Google Bookmark
Yahoo! Bookmark
Email
All News
|
News with Multimedia
>
Press Release: Repare Therapeutics Announces Phase 1 Data High...
Get Business Wire News on Your Website
Terms of Use
|
© 2024 Business Wire